Psilocybin for major depression in Stockholm: fast relief in a placebo-controlled trial
Photo: Robert Eklund on Unsplash
The question
Can a single dose of psilocybin with psychological support ease major depression faster than an active placebo? The trial also asked how long any effect lasts.
Who took part and what happened
The study was a double-blind, randomized, placebo-controlled trial. It ran at the Northern Stockholm Psychiatric Clinic between 2021 and 2024 and included 35 adults with moderate to severe recurrent major depression.
- 17 people received one oral dose of psilocybin, 25 mg.
- 18 people received niacin, 100 mg, a B vitamin that causes a warm flush. It was used as an active placebo.
Everyone received five psychological support sessions over 17 days.
What they found
- The main measure was the clinician-rated MADRS depression score on day 8. The psilocybin group improved by 7.3 points more than the placebo group (95% CI −12.9 to −1.7; P = .01).
- At one year, the difference between the groups was no longer statistically significant.
What this study does not tell us
The trial was small. Blinding did not work well: almost all participants correctly guessed their group. The groups differed at the start, and participants were recruited through social media, which can raise expectations. Two people in the psilocybin group had severe, lasting anxiety that needed medical attention. The benefit was clear in the short term but was not shown at one year.
Why it matters
The study adds a carefully controlled trial from Sweden to the growing evidence that psilocybin with support can quickly reduce depressive symptoms. It also points to the next question: how to keep the benefit going over time.
This is a summary of published research for general information. It is not medical advice. The study took place in a clinical research setting with medical screening and professional support.
Source: Yngwe H, Plavén-Sigray P, Ekman CJ, Henje E, Berglund A, Tiger M, Beckman M, Lundberg J, et al. (2026). Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression: A Randomized Clinical Trial. JAMA Network Open, 9(5), e2612589. ClinicalTrials.gov NCT04630964. doi:10.1001/jamanetworkopen.2026.12589 · PubMed · Full text
